Summary

HealthCare Global Enterprises Ltd (HCG), one of the largest providers of Cancer care in India, announced its financial results for the quarter and half year ended 30th September 2025. The company reported a revenue of Rs. 6,470 Mn for Q2FY26 and Rs. 12,601 Mn for H1FY26, representing a Y-o-Y growth of 16.9% and 16.8% respectively.

Key Highlights

1. 1

   Revenue for Q2FY26 is up by 169% Y-o-Y

2. 2

   Revenue for H1FY26 is up by 163% Y-o-Y

3. 3

   Adjusted EBITDA for Q2FY26 is up by 418.4% Y-o-Y

4. 4

   Profit After Tax for Q2FY26 is down by 9.6% Y-o-Y

5. 5

   Established Centers contributed 17.5% to the revenue in Q2FY26

6. 6

   Emerging Centers contributed 20.7% to the revenue in Q2FY26

7. 7

   LINAC capacity utilization on a like for like basis stood at 71% for Q2FY26

8. 8

   In-Patient bed occupancy stood at 66% in Q2FY26

9. 9

   OPD Volumes grew by 23% compared to same period last year

10. 10

    Overall ARPOB grew at 0.5% Y-o-Y to Rs. 44,355 in Q2FY26

11. 11

    Overall AOR stood at 70.3% in Q2FY26 vs. 67.2% in Q2FY25

12. 12

    PAT for the quarter stood at Rs. 163 mn compared to Rs. 180 mn